Lotus Pharmaceuticals (LTUS) Stock Price, News & Analysis

Company Overview

Lotus Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development, manufacture, and sale of pharmaceuticals in the People's Republic of China. The company is based in Nashville, Tennessee.

Key Stats

• Today's Range: $0.0062 to $0.0062
• 50-Day Range: $0.0044 to $0.0078
• 52-Week Range: $0.0006 to $0.0079
• Volume: 20,000 shs
• Average Volume: 55,940 shs
• Market Capitalization: $16.40 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

LTUS Stock Analysis - Frequently Asked Questions

How have LTUS shares performed this year?

Lotus Pharmaceuticals' stock was trading at $0.0060 on January 1st, 2025. Since then, LTUS shares have increased by 3.3% and is now trading at $0.0062.
View the best growth stocks for 2025 here.

How do I buy shares of Lotus Pharmaceuticals?

Shares of LTUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Lotus Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Lotus Pharmaceuticals investors own include Vodafone Group Public (VOD), TILT (TLLTF), SolarWinds (SWI), Spectra Energy Partners (SEP), NextEra Energy (NEE), Energy Transfer (ET) and Ameriwest Lithium (AWLID).

Company Calendar

• Today: 5/27/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:LTUS
• CIK: N/A
• Web: www.lotuspharma.com
• Phone: (941) 267-9684
• Fax: 86-10-6389-9867
• Employees: 230
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 2,644,516,000
• Free Float: N/A
• Market Cap: $16.40 million
• Optionable: Not Optionable
• Beta: -2.57